Swiss National Bank - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$704,064
-7.6%
231,6000.0%0.00%0.0%
Q2 2023$761,964
+7.8%
231,600
+4.2%
0.00%
Q1 2023$706,596
-45.2%
222,200
+19.3%
0.00%
-100.0%
Q4 2022$1,288,504
+60.3%
186,200
+12.3%
0.00%
Q1 2022$804,000
-46.0%
165,807
+11.2%
0.00%
-100.0%
Q4 2021$1,490,000
-47.7%
149,1070.0%0.00%
-50.0%
Q3 2021$2,849,000
-39.8%
149,107
+0.7%
0.00%
-33.3%
Q2 2021$4,733,000
+3.5%
148,007
-2.4%
0.00%0.0%
Q1 2021$4,571,000
-29.4%
151,607
+1.3%
0.00%
-40.0%
Q4 2020$6,478,000
-18.2%
149,707
+2.0%
0.01%
-16.7%
Q3 2020$7,915,000
-10.3%
146,707
+1.5%
0.01%
-14.3%
Q2 2020$8,821,000
+78.9%
144,507
+34.7%
0.01%
+40.0%
Q1 2020$4,932,000
-46.8%
107,307
+1.5%
0.01%
-50.0%
Q4 2019$9,276,000
-2.7%
105,707
+1.8%
0.01%0.0%
Q3 2019$9,532,000
-26.7%
103,807
+1.6%
0.01%
-28.6%
Q2 2019$13,001,000
-17.0%
102,207
+2.6%
0.01%
-17.6%
Q1 2019$15,671,000
+64.9%
99,607
+4.0%
0.02%
+41.7%
Q4 2018$9,504,000
-30.1%
95,807
+2.9%
0.01%
-20.0%
Q3 2018$13,594,000
-0.6%
93,107
+6.9%
0.02%
-6.2%
Q2 2018$13,671,000
-6.7%
87,107
+1.5%
0.02%
-11.1%
Q1 2018$14,652,000
-0.4%
85,807
+3.9%
0.02%
+12.5%
Q4 2017$14,712,000
+42.8%
82,607
+10.1%
0.02%
+33.3%
Q3 2017$10,302,000
+30.8%
75,0070.0%0.01%
+33.3%
Q2 2017$7,879,000
+29.7%
75,007
+12.3%
0.01%
+12.5%
Q1 2017$6,073,000
+47.3%
66,8070.0%0.01%
+33.3%
Q4 2016$4,122,000
+1.7%
66,807
+11.7%
0.01%0.0%
Q3 2016$4,054,000
+56.8%
59,807
+0.2%
0.01%
+50.0%
Q2 2016$2,585,000
+16.7%
59,707
+10.6%
0.00%0.0%
Q1 2016$2,215,000
-19.6%
54,007
+25.9%
0.00%
-42.9%
Q4 2015$2,755,000
-24.1%
42,907
+1.2%
0.01%
-22.2%
Q3 2015$3,628,000
-41.8%
42,407
+14.6%
0.01%
-43.8%
Q2 2015$6,231,000
+68.0%
37,007
+20.5%
0.02%
+60.0%
Q1 2015$3,708,000
+31.7%
30,7000.0%0.01%
-9.1%
Q4 2014$2,816,000
+274.0%
30,700
+46.2%
0.01%
+266.7%
Q3 2014$753,000
+18.4%
21,000
+27.3%
0.00%
+50.0%
Q2 2014$636,000
+131.3%
16,500
+36.4%
0.00%
+100.0%
Q1 2014$275,000
+205.6%
12,100
+181.4%
0.00%
Q4 2013$90,0004,3000.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders